Ingevity Corporation $NGVT Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in Ingevity Corporation (NYSE:NGVTFree Report) by 115.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,595 shares of the company’s stock after acquiring an additional 9,980 shares during the period. SG Americas Securities LLC owned about 0.05% of Ingevity worth $1,325,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of NGVT. Global Retirement Partners LLC purchased a new position in shares of Ingevity during the fourth quarter worth about $27,000. Meeder Asset Management Inc. acquired a new stake in shares of Ingevity during the fourth quarter worth about $33,000. Geneos Wealth Management Inc. lifted its holdings in shares of Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares during the last quarter. Headlands Technologies LLC purchased a new stake in shares of Ingevity in the 2nd quarter valued at about $46,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Ingevity in the 4th quarter valued at about $47,000. 91.59% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.88% of the company’s stock.

Ingevity Price Performance

Shares of NYSE:NGVT opened at $72.28 on Friday. The company has a 50-day simple moving average of $71.23 and a 200-day simple moving average of $69.10. Ingevity Corporation has a one year low of $39.74 and a one year high of $79.29. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. The stock has a market capitalization of $2.51 billion, a price-to-earnings ratio of -20.36 and a beta of 1.16.

Ingevity (NYSE:NGVTGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. The firm had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The business’s revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the company posted $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, analysts predict that Ingevity Corporation will post 5.05 EPS for the current year.

Analyst Ratings Changes

NGVT has been the topic of a number of research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 29th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $80.00.

View Our Latest Report on NGVT

About Ingevity

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Stories

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.